Summary:
A US-led trade deal is currently being negotiated that could increase the price of prescription drugs, weaken financial regulations and even allow partner countries to challenge American laws. But few know its substance.
Topics:
Dean Baker considers the following as important:
This could be interesting, too:
A US-led trade deal is currently being negotiated that could increase the price of prescription drugs, weaken financial regulations and even allow partner countries to challenge American laws. But few know its substance.
Topics:
Dean Baker considers the following as important:
This could be interesting, too:
Bill Haskell writes From the Middle Out and Bottom Up
Joel Eissenberg writes The business model of modern universities
Bill Haskell writes The Economics of Killing Medicaid . . .
Angry Bear writes Healthcare in the United States
|